30
Participants
Start Date
May 20, 2024
Primary Completion Date
October 30, 2028
Study Completion Date
December 31, 2028
Cabergoline 0.5 MG
Cabergoline (Dostinex ®) 0.5 mg/tablet. Cabergoline will be given orally 1mg/week (Day1-14), 2mg/week (Day15-end of the study).
National Taiwan University Hospital, Taipei
National Taiwan University Hospital Beihu Branch
OTHER
National Taiwan University
OTHER
National Taiwan University Hospital Hsin-Chu Branch
OTHER
National Taiwan University Hospital, Yun-Lin Branch
OTHER
National Taiwan University Hospital
OTHER